BioVariance GmbH
Our aim is to personalize and improve people’s health by using relevant data in the right context.
Our aim is to personalize and improve people’s health by using relevant data in the right context.
BioVariance GmbH, founded in 2013, is a Germany-based company dedicated to leveraging relevant data in the right context to personalize and enhance people's health. The company's multidisciplinary team focuses on developing innovative AI solutions for precision medicine in the healthcare, pharma, and biotech sectors. The company collaborates with physicians to provide long-term monitoring of molecular changes in patients, enabling the prediction of effectiveness, side effects, and drug interactions to determine optimal medication and dosage. BioVariance combines state-of-the-art automatization and parallelization techniques, machine learning, and mathematical algorithms to analyze complex biomedical data. Their commitment to driving personalized healthcare through advanced technology and data analysis makes them an intriguing prospect for investors seeking opportunities within the analytics, health care, and pharmaceutical industries. For more information, visit BioVariance's SlideShare profile. [https://www.slideshare.net/BioVariance]. Legal notice: http://www.biovariance.com/en/legal-notice/. Data privacy: http://www.biovariance.com/en/data-privacy/.
There is no investment information
No recent news or press coverage available for BioVariance GmbH.
We care about your data, and we'd love to use cookies make your experience better.
